Abstract
Long-term Survival in a WHO Grade 4 IDH-mutant Astrocytoma Using a Farnesyltransferase Inhibitor in Combination with Temozolomide (P4-5.006)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have